Bessemer Group
ALT icon

Bessemer Group’s Altimmune ALT Stock Holding History

Bessemer Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-660
Closed -$2.88K – 2520
2025
Q3 		$2K Sell
660
-43
-6% -$166 ﹤0.01% 2285
2025
Q2 		$3K Buy
703
+305
+77% +$1.65K ﹤0.01% 2106
2025
Q1 		$2K Buy
398
+18
+5% +$114 ﹤0.01% 2199
2024
Q4 		$3K Hold
380
– – ﹤0.01% 2104
2024
Q3 		$2K Buy
+380
New +$2.57K ﹤0.01% 2155

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bessemer Group's ALT Position: Q4 2025 in Review

Bessemer Group sold out of Altimmune (ALT) in Q4 2025, closing a stake of 660 shares — an estimated $2.88K sold.

Bessemer Group first reported a position in ALT in Q3 2024 and held it in 5 quarters. The position peaked at $3K in Q2 2025. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Bessemer Group reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Bessemer Group sold 660 Altimmune shares in Q4 2025, an estimated $2.88K.
  • Bessemer Group first reported a position in Altimmune in Q3 2024 and held it in 5 quarters.
  • Bessemer Group's Altimmune position peaked at $3K in Q2 2025.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.